Can an increased level of circulating IL-8 be a predictor of human longevity?

Medical Science Monitor

Volumn 12, Issue 3, 2006, Pages

  Wieczorowska Tobis, Katarzyna ^a   Niemir, Zofia I ^a   Podkówka, Renata ^a   Korybalska, Katarzyna ^a   Mossakowska, Małgorzata ^b   Brȩborowicz, Andrzej ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b INTERNATIONAL INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Poland)

Author keywords

Elderly; IL 6; IL 8; Inflammation

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLOOD LEVEL; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MALE; PREDICTOR VARIABLE;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LONGEVITY; MALE; PREDICTIVE VALUE OF TESTS; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY;

EID: 33644669117     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Caruso C, Candore G, Cigna D et al: Cytokine production pathway in the elderly. Immunol Res, 1996; 15: 84-90
2. Mysliwska J, Bryl E, Foerster J, Mysliwski A: Increase of interleukin 6 and decrease of interleukin 2 production during the ageing process are influenced by the health status. Mech Ageing Dev, 1998; 100: 313-28
3. th edition. New York, Churchill Livingstone, 2003; 113-22
4. Ligthart GJ, Corberand JX, Fournier C et al: Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Ageing Dev, 1984; 28: 47-55
5. Karasik D, Demissie S, Cupples LA, Kiel DP: Disentangling the genetic determinants of human aging: biological age as an alternative to the use of survival measures. J Gerontol A Biol Sci Med Sci, 2005; 60: 574-87
6. Reuben DB, Judd-Hamilton L, Harris TB, Seeman TE: The associations between physical activity and inflammatory markers in high-functioning older persons: MacArthur Studies of Successful Aging. J Am Geriatr Soc, 2003; 51: 1125-30
7. Reuben DB, Cheh AI, Harris TB et al: Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc, 2002; 50: 638-44
8. Harris TB, Ferrucci L, Tracy RP et al: Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med, 1999; 106: 506-12
9. Rea IM, Ross OA, Armstrong M et al: Interleukin-6-gene C/G 174 polymorphism in nonagenarian and octogenarian subjects in the BELFAST study. Reciprocal effects on IL-6, soluble IL-6 receptor and for IL-10 in serum and monocyte supernatants. Mech Ageing Dev, 2003; 124: 555-61
10. Baggiolini M, Clark-Lewis I: Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett, 1992; 307: 97-101
11. Tikhonov I, Rebenok A, Chyzh A: A study of interleukin-8 and defensins in urine and plasma of patients with pyelonephritis and glomerulonephritis. Nephrol Dial Transplant, 1997; 12: 2557-61
12. Bartuzi Z, Zbikowska-Gotz M, Romanski B, Sinkiewicz: Evaluating the profile of selected cytokines in patients with food allergy and chronic gastritis. Med Sci Monit, 2000; 6: 1128-35
13. Zhou RH, Shi Q, Gao HQ, Shen BJ: Changes in serum interleukin-8 and interleukin-12 levels in patients with ischemic heart disease in a Chinese population. J Atheroscler Thromb, 2001; 8: 30-32
14. Gimbrone MA Jr, Obin MS, Brock AF et al: Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions. Science, 1989; 246: 1601-3
15. Li A, Dubey S, Varney ML et al: IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol, 2003; 170: 3369-76
16. Terui Y, Ikeda M, Tomizuka H et al: Activated endothelial cells induce apoptosis in leukemic cells by endothelial interleukin-8. Blood, 1998; 92: 2672-80
17. Simonet WS, Hughes TM, Nguyen HQ et al: Long-term impaired neutrophil migration in mice overexpressing human interleukin-8. J Clin Invest, 1994; 94: 1310-19
18. Lefer AM, Johnson G III, Ma XL et al: Cardioprotective and endothelial protective effects of [Ala-IL8]77 in a rabbit model of myocardial ischaemia and reperfusion. Br J Pharmacol, 1919; 103: 1153-59
19. Niemir ZI, Stein H, Ciechanowicz A et al.: The in situ expression of interleukin-8 in the normal human kidney and in different morphological forms of glomerulonephritis. Am J Kidney Dis, 2004; 43: 983-98
20. Ferrucci L, Penninx BW, Leveille SG et al: Characteristics of nondisabled older persons who perform poorly in objective tests of lower extremity function. J Am Geriatr Soc, 2000; 48: 1102-10
21. Visser M, Pahor M, Taaffe DR et al: Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study. J Gerontol A Biol Sci Med Sci, 2002; 57: M326-32
22. Meyer KC, Rosenthal NS, Soergel P, Peterson K: Neutrophils and lowgrade inflammation in the seemingly normal aging human lung. Mech Ageing Dev, 1998; 104: 169-81
23. Hebert CA, Luscinskas FW, Kiely JM et al: Endothelial and leukocyte forms of IL-8. Conversion by thrombin and interactions with neutrophils. J Immunol, 1990; 145: 3033-40
24. Nourshargh S, Perkins JA, Showell HJ et al: A comparative study of the neutrophil stimulatory activity in vitro and pro-inflammatory properties in vivo of 72 amino acid and 77 amino acid IL-8. J Immunol, 1992; 148: 106-11
25. Rennekampff HO, Hansbrough JF, Kiessig V et al: Bioactive interleukin-8 is expressed in wounds and enhances wound healing. J Surg Res, 2000; 93: 41-54